Suppression of follicular phase pituitary-gonadal function by a potent new gonadotropin-releasing hormone antagonist with reduced histamine-releasing properties (ganirelix)

Fertility and Sterility
L R NelsonS E Monroe

Abstract

To determine if daily subcutaneous doses of ganirelix will suppress and maintain E2 < or = 30 pg/mL (conversion factor to SI unit, 3.671), the serum profiles of LH and FSH during and after cessation of treatment, the time-course of the resumption of normal ovarian function after ganirelix cessation, and to identify side effects of daily treatment. Open-label nonrandomized clinical study. Normal human volunteers in an academic research center. Women 21 to 45 years of age, with documented ovulatory menstrual cycles. Ganirelix was administered subcutaneously daily for 8 days. Blood samples were obtained during dosing as well as before and after cessation of dosing. Changes in serum E2, LH, FSH, P, and ganirelix. Ganirelix treatment rapidly decreased serum levels of gonadotropins and E2 after both 1 and 2 mg administration. Twenty-four hours after the first dose of ganirelix, E2 decreased from a mean +/- SEM of 50 +/- 8 and 67 +/- 11 pg/mL at baseline to 25 +/- 4 and 20 +/- 3 in the 1 mg and 2 mg groups, respectively. Estradiol remained suppressed (mean levels < 26 pg/mL) on all subsequent 7 days of ganirelix dosing in both groups. After the final dose of ganirelix, there was a rapid return of ovarian function in all volunteers. Al...Continue Reading

Citations

Jun 15, 2011·Current Opinion in Obstetrics & Gynecology·Orkun Tan, Orhan Bukulmez
Aug 11, 2017·Clinical and Experimental Reproductive Medicine·Neil Chappell, William E Gibbons
Feb 1, 1997·Endocrine Reviews·B C Fauser, A M Van Heusden
Feb 18, 2006·Journal of Endocrinological Investigation·F P HohmannB C J M Fauser
Apr 28, 2017·The Prostate·Andrew V SchallyFerenc G Rick
Sep 8, 2005·Expert Opinion on Investigational Drugs·Askan Schultze-MosgauKlaus Diedrich
Jan 23, 2004·American Journal of Physiology. Endocrinology and Metabolism·Christopher R McCartneyJohannes D Veldhuis
Mar 23, 2017·The Journal of Clinical Endocrinology and Metabolism·Juki NgCheri E Klein
Dec 4, 2019·The Journal of Clinical Endocrinology and Metabolism·Ferdinand RoelfsemaJohannes D Veldhuis
Mar 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Judit E HorvathKate Groot
Apr 7, 2009·Irish Journal of Medical Science·E V MocanuC Hughes
Mar 30, 2016·Expert Opinion on Drug Metabolism & Toxicology·Gian Benedetto MelisAnna Maria Paoletti
Oct 6, 2001·Frontiers in Neuroendocrinology·A V SchallyG Halmos
Jun 16, 2004·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Maria Elisabetta CocciaGianfranco Scarselli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.